FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jonathan Serody

Research Profile

Disorders

Living Beings

Procedures

Anatomy

Chemicals & Drugs

Physiology

Graft Survival

Co-author Network

Publications

TOP 3
Hendrik W van Deventer; Qing Ping Wu; Everett C McCook; Daniela A Palmieri; Jonathan S Serody
Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2.
William A Wood; Amy Abernethy; Ethan Basch; Claudio Battaglini; Allison M Deal; Yoon Hie Kim; Jonathan S Serody; Charlotte Shatten; Thomas C Shea; Julia Whitley; Bryce B Reeve
Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.
Jessica L Allen; Paul Armistead; Albert S Baldwin; Nazmim S Bhuiya; James Coghill; Corey Cutler; Allison M Deal; Amber Essenmacher; Matthew S Fore; Don A Gabriel; Todd Hoffert; Robert Irons; Kristy Richards; Jerome Ritz; Philip A Roehrs; Jonathan S Serody; Andrew Sharf; Thomas C Shea; Jenna Wooten; Stefanie Sarantopoulos
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jonathan Serody (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hendrik W van Deventer; Qing Ping Wu; Everett C McCook; Daniela A Palmieri; Jonathan S Serody
Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(9):4861-7.
2013: William A Wood; Amy Abernethy; Ethan Basch; Claudio Battaglini; Allison M Deal; Yoon Hie Kim; Jonathan S Serody; Charlotte Shatten; Thomas C Shea; Julia Whitley; Bryce B Reeve
Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):450-9.
2012: Jessica L Allen; Paul Armistead; Albert S Baldwin; Nazmim S Bhuiya; James Coghill; Corey Cutler; Allison M Deal; Amber Essenmacher; Matthew S Fore; Don A Gabriel; Todd Hoffert; Robert Irons; Kristy Richards; Jerome Ritz; Philip A Roehrs; Jonathan S Serody; Andrew Sharf; Thomas C Shea; Jenna Wooten; Stefanie Sarantopoulos
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
Blood 2012;120(12):2529-36.
2012: LeShara M Fulton; Dan R Littman; Laura E Ott; Angela Panoskaltsis-Mortari; Bruce R Blazar; Michael J Carlson; James M Coghill; Michelle L West; Jonathan S Serody
Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(4):1765-72.
2012: Jonathan S Serody
Bacterial sepsis and GI tract GVHD: more commensal than you think.
Blood 2012;120(1):6-7.
2012: Yuri Fedoriw; T Danielle Samulski; Allison M Deal; Cherie H Dunphy; Jonathan S Serody; Andrew Sharf; Thomas C Shea; Stefanie Sarantopoulos
Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):968-73.
2012: Jonathan S Serody; Geoffrey R Hill
The IL-17 differentiation pathway and its role in transplant outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(1 Suppl):S56-61.
2011: William Wood; Julia Whitley; Allison Deal; Donald Gabriel; Jonathan S Serody; Andrew Sharf; Thomas C Shea
Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant.
Pediatric blood & cancer 2011;57(3):499-505.
2011: James M Coghill; Stefanie Sarantopoulos; Timothy P Moran; William Murphy; Bruce R Blazar; Jonathan S Serody
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.
Blood 2011;117(12):3268-76.
2011: Anne W Beaven; Dominic T Moore; Andrew Sharf; Jonathan S Serody; Thomas C Shea; Don A Gabriel
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.
Cancer investigation 2011;29(3):214-9.
2011: William A Wood; Julia Whitley; Dominic Moore; Andrew Sharf; Robert Irons; Kamakshi Rao; Jonathan S Serody; Jay Coghill; Donald Gabriel; Thomas Shea
Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1):141-6.
2010: Steven L Highfill; Paulo C Rodriguez; Qing Zhou; Christine A Goetz; Brent H Koehn; Rachelle Veenstra; Patricia A Taylor; Angela Panoskaltsis-Mortari; Jonathan S Serody; David H Munn; Jakub Tolar; Augusto C Ochoa; Bruce R Blazar
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
Blood 2010;116(25):5738-47.
2010: Hendrik W van Deventer; Joseph E Burgents; Qing Ping Wu; Rita-Marie T Woodford; W June Brickey; Irving C Allen; Erin McElvania-Tekippe; Jonathan S Serody; Jenny P-Y Ting
The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.
Cancer research 2010;70(24):10161-9.
2010: M J Carlson; L M Fulton; J M Coghill; M L West; J E Burgents; Y Wan; A Panoskaltsis-Mortari; Thomas F Tedder; B R Blazar; Jonathan S Serody
L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010;10(12):2596-603.
2010: James M Coghill; Michael J Carlson; Angela Panoskaltsis-Mortari; Michelle L West; Joseph E Burgents; Bruce R Blazar; Jonathan S Serody
Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells.
Blood 2010;115(23):4914-22.
2010: Joseph E Burgents; Timothy P Moran; Michelle L West; Nancy L Davis; Robert E Johnston; Jonathan S Serody
The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in Neu transgenic mice.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(5):482-91.
2010: William Wood; Seema Garg; Grazyna Adamus; Don A Gabriel; Thomas C Shea; Jonathan S Serody
Alloimmune retinopathy associated with antibodies to transducin-alpha as a complication of chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):135-8.
2009: Thomas C Shea; Anne W Beaven; Dominic T Moore; Jonathan S Serody; Don A Gabriel; Nelson Chao; Jon P Gockerman; Reynaldo A Garcia; David A Rizzieri
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
Leukemia & lymphoma 2009;50(5):741-8.
2009: Matthew J O'Shaughnessy; C Vogtenhuber; K Sun; R Sitcheran; A S Baldwin; William Murphy; L Dang; B Jaffee; E Palmer; Jonathan S Serody; Bruce R Blazar
Ex vivo inhibition of NF-kappaB signaling in alloreactive T-cells prevents graft-versus-host disease.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(3):452-62.
2009: Kamakshi V Rao; Larry W Buie; Thomas C Shea; Don A Gabriel; Terrance Comeau; Robert Irons; Jonathan S Serody; Barbara Eron; Stacy Epstein
Intravesicular cidofovir for the management of BK virus-associated cystitis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):391-2.
2009: Michael J Carlson; Michelle L West; James M Coghill; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.
Blood 2009;113(6):1365-74.
2008: Amanda Peppercorn; Jonathan S Serody; Bruce A Cairns
Reactivation of cytomegalovirus infection in critically ill immunocompetent patients.
JAMA : the journal of the American Medical Association 2008;300(20):2367-8; author reply 2368.
2008: Patricia A Taylor; Michael J Ehrhardt; Christopher J Lees; Angela Panoskaltsis-Mortari; Arthur M Krieg; Arlene H Sharpe; William Murphy; Jonathan S Serody; Hiroaki Hemmi; Shizuo Akira; Robert B Levy; Bruce R Blazar
TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.
Blood 2008;112(8):3508-16.
2008: James M Coghill; Michael J Carlson; Tim P Moran; Jonathan S Serody
The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting.
Leukemia & lymphoma 2008;49(10):1860-9.
2008: Hendrik W van Deventer; Qing Ping Wu; Daniel T Bergstralh; Beckley K Davis; Brian P O'Connor; Jenny P-Y Ting; Jonathan S Serody
C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.
The American journal of pathology 2008;173(1):253-64.
2007: Kimberly B Petermann; Gabriela I Rozenberg; Daniel Zedek; Pamela A Groben; Karen P McKinnon; Christin Buehler; William Kim; Janiel M Shields; Shannon Penland; James E Bear; Nancy E Thomas; Jonathan S Serody; Norman E Sharpless
CD200 is induced by ERK and is a potential therapeutic target in melanoma.
The Journal of clinical investigation 2007;117(12):3922-9.
2007: Patricia A Taylor; Michael J Ehrhardt; Christopher J Lees; Jakub Tolar; Brenda J Weigel; Angela Panoskaltsis-Mortari; Jonathan S Serody; Volker Brinkmann; Bruce R Blazar
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD).
Blood 2007;110(9):3480-8.
2007: Timothy P Moran; Joseph E Burgents; Brian Long; Ivana Ferrer; Elizabeth M Jaffee; Roland Tisch; Robert E Johnston; Jonathan S Serody
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice.
Vaccine 2007;25(36):6604-12.
2007: Patricia A Taylor; Michael J Ehrhardt; Matthew M Roforth; Jessica M Swedin; Angela Panoskaltsis-Mortari; Jonathan S Serody; Bruce R Blazar
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients.
Blood 2007;109(3):1307-15.
2006: Andrew Gilman; Jonathan S Serody
Diagnosis and treatment of chronic graft-versus-host disease.
Seminars in hematology 2006;43(1):70-80.
2005: Don A Gabriel; Thomas C Shea; Jonathan S Serody; Dominic T Moore; Suzanne L Kirby; Donald Harvey; Carol Krasnov
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):1022-30.
2005: Christian A Wysocki; Qi Jiang; Angela Panoskaltsis-Mortari; Patricia A Taylor; Karen P McKinnon; Lishan Su; Bruce R Blazar; Jonathan S Serody
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.
Blood 2005;106(9):3300-7.
2005: Timothy P Moran; martha collier; Karen P McKinnon; Nancy L Davis; Robert E Johnston; Jonathan S Serody
A novel viral system for generating antigen-specific T cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(5):3431-8.
2005: Christian A Wysocki; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Leukocyte migration and graft-versus-host disease.
Blood 2005;105(11):4191-9.
2005: Hendrik W van Deventer; William O'Connor; W June Brickey; Robert M Aris; Jenny P-Y Ting; Jonathan S Serody
C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis.
Cancer research 2005;65(8):3374-9.
2005: Patricia A Taylor; Angela Panoskaltsis-Mortari; Gordon J Freeman; Arlene H Sharpe; Randolph J Noelle; Alexander Y Rudensky; Tak W Mak; Jonathan S Serody; Bruce R Blazar
Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Blood 2005;105(8):3372-80.
2005: Gerhard C Hildebrandt; Krystyna M Olkiewicz; Sung Won Choi; Leigh A Corrion; Shawn G Clouthier; Chen Liu; Jonathan S Serody; Kenneth R Cooke
Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation.
Blood 2005;105(6):2249-57.
2004: Patricia A Taylor; Angela Panoskaltsis-Mortari; Jessica M Swedin; Philip J Lucas; Ronald E Gress; Bruce L Levine; Carl H June; Jonathan S Serody; Bruce R Blazar
L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
Blood 2004;104(12):3804-12.
2004: Bruce R Blazar; Robert B Levy; Tak W Mak; Angela Panoskaltsis-Mortari; Hiromi Muta; Monica Jones; Melinda Roskos; Jonathan S Serody; Hideo Yagita; Eckhard R Podack; Patricia A Taylor
CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(5):2933-41.
2004: Elizabeth Dees; Karen P McKinnon; Jennifer J Kuhns; Kathryn A Chwastiak; Scotty Sparks; Mary Myers; Edward J Collins; Jeffrey Frelinger; Hendrik W van Deventer; Frances A Collichio; Lisa A Carey; Mark E Brecher; Mark Graham II; Henry Earp; Jonathan S Serody
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer.
Cancer immunology, immunotherapy : CII 2004;53(9):777-85.
2004: Christian A Wysocki; Susan B Burkett; Angela Panoskaltsis-Mortari; Suzanne L Kirby; Andrew D Luster; Karen P McKinnon; Bruce R Blazar; Jonathan S Serody
Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(2):845-54.
2004: Martin G Sauer; Marna E Ericson; Brenda J Weigel; Michael J Herron; Angela Panoskaltsis-Mortari; Betsy T Kren; Bruce L Levine; Jonathan S Serody; Carl H June; Patricia A Taylor; Bruce R Blazar
A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells.
Cancer research 2004;64(11):3914-21.
2004: Celeste Lindley; Thomas C Shea; Jeannine McCune; Stacy S Shord; Jodi Decker; Donald Harvey; William P Petros; Don Garbriel; Jonathan S Serody; Suzanne L Kirby; Joseph Wiley
Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy.
Anti-cancer drugs 2004;15(5):453-9.
2004: Kai Sun; Lisbeth A Welniak; Angela Panoskaltsis-Mortari; Matthew J O'Shaughnessy; Haiyan Liu; Isabel Barao; William Riordan; Raquel Sitcheran; Christian Wysocki; Jonathan S Serody; Bruce R Blazar; Thomas J Sayers; William Murphy
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(21):8120-5.
2004: Angela Panoskaltsis-Mortari; Andrew Price; John R Hermanson; Elizabeth Taras; Chris Lees; Jonathan S Serody; Bruce R Blazar
In vivo imaging of graft-versus-host-disease in mice.
Blood 2004;103(9):3590-8.
2003: Don A Gabriel; Thomas C Shea; Oludamilola Olajida; Jonathan S Serody; Terrance Comeau
The effect of oral mucositis on morbidity and mortality in bone marrow transplant.
Seminars in oncology 2003;30(6 Suppl 18):76-83.
2003: Thomas C Shea; Rebecca Bruner; Joseph M Wiley; Jonathan S Serody; Scott Sailer; Don A Gabriel; Eileen Capel; Dominic T Moore; Georgette Dent; Stuart Bentley; Mark E Brecher
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):443-52.
2003: Angela Panoskaltsis-Mortari; John R Hermanson; Elizabeth Taras; O Douglas Wangensteen; Jonathan S Serody; Bruce R Blazar
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice.
Blood 2003;101(9):3714-21.
2003: Judith Ng-Cashin; Jennifer J Kuhns; Susan E Burkett; John D Powderly; Robin R Craven; Hendrik W van Deventer; Suzanne L Kirby; Jonathan S Serody
Host absence of CCR5 potentiates dendritic cell vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(8):4201-8.
2002: Hendrik W van Deventer; Jonathan S Serody; Karen P McKinnon; Casey Clements; W June Brickey; Jenny P-Y Ting
Transfection of macrophage inflammatory protein 1 alpha into B16 F10 melanoma cells inhibits growth of pulmonary metastases but not subcutaneous tumors.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(3):1634-9.
2000: Jonathan S Serody; S E Burkett; A Panoskaltsis-Mortari; Judith Ng-Cashin; Eileen J McMahon; Glenn K Matsushima; sergio lira; Donald N Cook; B R Blazar
T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.
Blood 2000;96(9):2973-80.
2000: Jonathan S Serody; M M Berrey; K Albritton; S M O'Brien; E P Capel; S H Bigelow; David J Weber; Joseph M Wiley; Michael J Schell; Peter H Gilligan; Thomas C Shea
Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.
Bone marrow transplantation 2000;26(5):533-8.
2000: Jonathan S Serody; Edward J Collins; Roland Tisch; Jennifer J Kuhns; Jeffrey Frelinger
T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4961-7.
2000: Jonathan S Serody; S D Sparks; Y Lin; Eileen Capel; S H Bigelow; Suzanne L Kirby; Don A Gabriel; Joseph M Wiley; Mark E Brecher; Michael J Schell; James D Folds; Thomas C Shea
Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4A):434-40.
1999: Donald N Cook; Oliver Smithies; R M Strieter; Jeffrey Frelinger; Jonathan S Serody
CD8+ T cells are a biologically relevant source of macrophage inflammatory protein-1 alpha in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(9):5423-8.
1999: Jonathan S Serody; Donald N Cook; Suzanne L Kirby; Elizabeth A Reap; Thomas C Shea; Jeffrey Frelinger
Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.
Blood 1999;93(1):43-50.
1998: Jeffrey Frelinger; Jonathan S Serody
Immune response of beta 2-microglobulin-deficient mice to pathogens.
Current topics in microbiology and immunology 1998;232():99-114.
1997: Jonathan S Serody; Thomas C Shea
Prevention of infections in bone marrow transplant recipients.
Infectious disease clinics of North America 1997;11(2):459-77.
1997: Jonathan S Serody; Mark E Brecher; Georgette Dent; Stuart Bentley; Jeffrey Frelinger; Thomas C Shea
A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes.
Cancer research 1997;57(8):1547-53.
1997: Stuart Bentley; Mark E Brecher; E Powell; Jonathan S Serody; Joseph M Wiley; Thomas C Shea
Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
Bone marrow transplantation 1997;19(6):557-63.
1996: Jonathan S Serody; R M Poston; D Weinstock; Roger Kurlander; Jeffrey Frelinger
CD4+ cytolytic effectors are inefficient in the clearance of Listeria monocytogenes.
Immunology 1996;88(4):544-50.
1996: Nicholas Bandarenko; Mark E Brecher; H Owen; J Wiley; T Shea; Jonathan S Serody
Thrombocytopenia in allogeneic peripheral blood stem cell collections.
Transfusion 1996;36(7):668-9.
1995: John H Rex; JOHN BENNETT; A M Sugar; P G Pappas; Jonathan S Serody; John Edwards; R G Washburn
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(4):994-6.
1995: Thomas C Shea; Mark Graham II; Stephen A Bernard; A Steagall; J Wiley; Jonathan S Serody; Mark E Brecher; Stuart Bentley; C Johnston; Alexandra Vaisman
A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer.
Seminars in oncology 1995;22(5 Suppl 12):80-5.
1994: Bradley E Britigan; Jonathan S Serody; M S Cohen
The role of lactoferrin as an anti-inflammatory molecule.
Advances in experimental medicine and biology 1994;357():143-56.
1993: Jonathan S Serody; Michael R Mill; Frank C Detterbeck; D T Harris; Myron S Cohen
Blastomycosis in transplant recipients: report of a case and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(1):54-8.
1992: M S Cohen; J Mao; G T Rasmussen; Jonathan S Serody; Bradley E Britigan
Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation.
The Journal of infectious diseases 1992;166(6):1375-8.
1991: Bradley E Britigan; Jonathan S Serody; M B Hayek; L M Charniga; M S Cohen
Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(12):4271-7.